RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odense University Hospital, part of the South Denmark Region, for its RayStation treatment planning system.
Odense University Hospital's radiotherapy centre, a leader in automated treatment planning, aims to further expand automation across the entire planning process, from initial assessments to finalised treatment plans. RayStation was selected following an extensive market evaluation focused on supporting continued innovation in automation.
RayStation integrates both machine learning and traditional planning algorithms. Its upcoming version will feature a new auto-optimisation algorithm, currently under development in collaboration with Memorial Sloan Kettering Cancer Center.
Most of the revenue from the order is expected to be recognized in the first quarter of 2025. The agreement excludes a service contract and remains subject to regulatory clearance in certain markets.
(USD1.00 = DKK6.57)
Natera to support Phase 1 trial of Kupando's immunotherapy in advanced skin cancers
AlzeCure completes QuantumCell transaction with USD12m upfront payment
Galvanize Therapeutics' new Aliya EX System completes first commercial procedures
Laekna's New Drug Application for LAE002 (afuresertib) accepted by China's NMPA
Alfasigma to acquire Nordic Pharma, expanding specialty care portfolio
Labcorp receives FDA approval for melanoma companion diagnostic
BeOne Medicines and Revolution Medicines expand oncology collaboration
ValiRx receives notice of intention to grant Cytolytix European patent
ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon
Akeso Advances reports first patient dosed in AK146D1 combined with ivonescimab breast cancer study
BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer
Northwest Biotherapeutics signs MOU for collaboration with SPIMACO in Saudi Arabia